Evidence-based review of the black-box warning for droperidol

Authors:

Abstract
Purpose. Data collected from the Food and Drug Administration (FDA) under the Freedom of Information Act are presented to help clinicians understand the data prompting the black-box warning for droperidol and to make educated decisions regarding the use of droperidol and alternative agents.

This publication has 19 references indexed in Scilit: